Author

Fahsai Kantawong

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Long non-coding RNA-gm33782 exacerbates acute kidney injury by upregulating the PA1-MLL3/MLL4 complex and promoting histone H3 lysine 4 monomethylation-dependent forkhead box O3 enhancer activation.

A conserved lncRNA-PA1-MLL3/4-Foxo3 epigenetic axis that drives enhancer reprogramming and a self-reinforcing Foxo3 circuit is uncovered and is positioned as a promising therapeutic target and its human homolog as a circulating biomarker for AKI.

Rui-Zhi Tan, Jian Jia, Qiu-Xiang Bai et al. · International Journal of Bio... · 0 citations

Review Aug 2026

The Therapeutic Application of Epigenetic Regulation by Natural Herbal Compounds in Kidney Diseases.

Overall, this review highlights the promise of epigenetics-based therapeutic strategies using herbal active ingredients for kidney disease intervention, though further validation and optimization are needed for clinical application.

Qiu-Xiang Bai, Kang Luo, Long-hao Jia et al. · Seminars in Nephrology · 0 citations

#gene editing Review Open access Aug 2026

Next-generation vascular organoids: multi-lineage and immune integration for disease modeling and regenerative medicine

Traditional human blood vessel organoids, built primarily around endothelial monocultures, fail to replicate the multicellular architecture and dynamic immunological functions of native microvasculature. This review synthesizes an emerging paradigm shift toward third-generation, multi-lineage, and immune-competent vasc...

Qiao-Wen Chen, Jia-Le Jin, Fahsai Kantawong et al. · Vessel Plus · 0 citations